Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
35
pubmed:dateCreated
1993-1-12
pubmed:abstractText
The leukocyte integrin alpha 4 beta 1 (VLA-4, CD49d/CD29) is a receptor for the extracellular matrix protein fibronectin and the endothelial adhesion protein VCAM-1. We have analyzed the biosynthesis and post-translational modifications of the two subunits of this receptor complex. The alpha 4 subunit was initially synthesized as a single-chain polypeptide that underwent the formation of complex endoglycosidase H-resistant oligosaccharide side chains and which could be proteolytically cleaved into two noncovalently associated fragments. The level and rate of alpha 4 subunit cleavage was dependent on the cell studied. The T cell tumor line HPB-ALL expressed both intact and fragmented alpha 4 on the cell surface. The interleukin-2-dependent natural killer line NK 3.3 and long term interleukin-2-dependent activated T lymphocytes cleaved the alpha 4 polypeptide earlier and more efficiently than did HPB-ALL cells and did not have detectable levels of intact alpha 4 on the cell surface. The proteolysis of alpha 4 was blocked by treating cells with either the lysosomotrophic amine NH4Cl or the carboxylic ionophore monensin. The presence of complex N-linked oligosaccharides did not seem to be necessary for alpha 4 cleavage or for binding of the alpha 4 beta 1 complex to a synthetic peptide corresponding to the binding site for this receptor on fibronectin.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
267
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
25274-81
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:1281155-Amino Acid Sequence, pubmed-meshheading:1281155-Antibodies, Monoclonal, pubmed-meshheading:1281155-Epitopes, pubmed-meshheading:1281155-Fibronectins, pubmed-meshheading:1281155-Glycoside Hydrolases, pubmed-meshheading:1281155-Humans, pubmed-meshheading:1281155-Immunoblotting, pubmed-meshheading:1281155-Integrin alpha4beta1, pubmed-meshheading:1281155-Integrins, pubmed-meshheading:1281155-Interleukin-2, pubmed-meshheading:1281155-Leukocytes, pubmed-meshheading:1281155-Macromolecular Substances, pubmed-meshheading:1281155-Molecular Sequence Data, pubmed-meshheading:1281155-Peptides, pubmed-meshheading:1281155-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:1281155-Protease Inhibitors, pubmed-meshheading:1281155-Protein Processing, Post-Translational, pubmed-meshheading:1281155-Receptors, Very Late Antigen, pubmed-meshheading:1281155-T-Lymphocytes, pubmed-meshheading:1281155-Tumor Cells, Cultured
pubmed:year
1992
pubmed:articleTitle
Post-translational processing of the leukocyte integrin alpha 4 beta 1.
pubmed:affiliation
Department of Immunology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't